DelveInsight has launched a new report on “Postpartum Depression (PPD) – Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Postpartum Depression (PPD) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Postpartum Depression (PPD), historical and forecasted epidemiology as well as the Postpartum Depression (PPD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key benefits of the report:
1. Postpartum Depression (PPD) market report covers a descriptive overview and comprehensive insight of the Postpartum Depression (PPD) epidemiology and Postpartum Depression (PPD) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. The Postpartum Depression (PPD) market report provides insights on the current and emerging therapies.
3. Postpartum Depression (PPD) market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. The Postpartum Depression (PPD) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Postpartum Depression (PPD) market.
Request for sample pages: https://www.delveinsight.com/sample-request/postpartum-depression-market
Postpartum Depression (PPD): Overview
Postpartum depression (PPD) is a complex mix of physical, emotional, and behavioral changes that happen in some women after giving birth. According to the DSM-5, a manual used to diagnose mental disorders, PPD is a form of major depression that begins within 4 weeks after delivery. The diagnosis of postpartum depression is based not only on the length of time between delivery and onset but on the severity of the depression.
The key players involved in the Postpartum Depression (PPD) market:
-
Sage Therapeutics
-
Marinus Pharmaceuticals
The launch of the emerging therapies is expected to significantly impact the Postpartum Depression (PPD) treatment scenario in the upcoming years:-
Drug covered
-
Zuranolone (SAGE-217)
-
Ganaxolone
Request a free sample report @https://www.delveinsight.com/sample-request/postpartum-depression-market
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Postpartum Depression (PPD) Patient Share (%) Overview at a Glance
5. Postpartum Depression (PPD) Market Overview at a Glance
6. Postpartum Depression (PPD) Disease Background and Overview
7. Postpartum Depression (PPD) Epidemiology and Patient Population
8. Country-Specific Patient Population of Postpartum Depression (PPD)
9. Postpartum Depression (PPD) Current Treatment and Medical Practices
10. Unmet Needs
11. Postpartum Depression (PPD) Emerging Therapies
12. Postpartum Depression (PPD) Market Outlook
13. Country-Wise Postpartum Depression (PPD) Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Postpartum Depression (PPD) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/